Salarius Pharmaceuticals, Inc. Gains 59.15%

Thu, Jul 18, 2024 at 07:14 PM
Salarius Pharmaceuticals, Inc. Gains 59.15%

Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ) soared at $2.44, a gain of 59.2%. On Thu, Jul 18, 2024, SLRX:NASDAQ hit a New 2-Week Intraday High of $2.92. From Fri, Jul 05, 2024, the stock recorded 44.44% Up Days and 40.00% Green Days

About Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ)

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.